How much funding has Zxerex raised?

Zxerex has disclosed $1.4M raised across 2 rounds.

Where is Zxerex headquartered?

Zxerex is headquartered in Scottsdale, US.

Zxerex

Scottsdale, US · Founded 2016 · Delaware corporation

ZXEREX develops a science-based impairment screening technology, enhanced with AI and machine learning, that detects temporary neurologic impairment from drugs, alcohol, or fatigue by measuring the drug's effects on the brain rather than its presence in the body. Its products ZXEREX-Safe and Impair-ID offer non-invasive, fast (2-3 minute) impairment tests aimed at workplace safety programs to reduce accidents and injuries.

AI & Machine Learning Deep Tech Healthtech

Founders & leadership

MARK K. ATTINGERNamed on SEC filing

RICHARD DALENamed on SEC filing

RICHARD BESSERMANNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 2 rounds · 2017–2019

▶$50KraisedOct 2019 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Richard BessermanExecutive Officer, Director
Mike EffingerExecutive Officer
Gregory SchwimerExecutive Officer
Julie DaleDirector

Offering amount: $500K
Amount sold: $50K
First sale: Sep 2019
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.4MraisedDec 2017 · 6 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

MARK K. ATTINGERExecutive Officer, Director
RICHARD DALEExecutive Officer, Director
RICHARD BESSERMANExecutive Officer, Director

Offering amount: $5M
Amount sold: $1.4M
Minimum investment: $120K
Proceeds to insiders: $800K
First sale: Apr 2017
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Zxerex do?: ZXEREX develops a science-based impairment screening technology, enhanced with AI and machine learning, that detects temporary neurologic impairment from drugs, alcohol, or fatigue by measuring the drug's effects on the brain rather than its presence in the body. Its products ZXEREX-Safe and Impair-ID offer non-invasive, fast (2-3 minute) impairment tests aimed at workplace safety programs to reduce accidents and injuries.
How much funding has Zxerex raised?: Zxerex has disclosed $1.4M raised across 2 rounds.
Where is Zxerex headquartered?: Zxerex is headquartered in Scottsdale, US.